CHINA PHARMA HOLDINGS, INC. Quarterly Cost of Revenue in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
China Pharma Holdings, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2010 to Q3 2024.
  • China Pharma Holdings, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $1.62M, a 20.5% decline year-over-year.
  • China Pharma Holdings, Inc. annual Cost of Revenue for 2023 was $7.29M, a 15.2% decline from 2022.
  • China Pharma Holdings, Inc. annual Cost of Revenue for 2022 was $8.6M, a 7.48% decline from 2021.
  • China Pharma Holdings, Inc. annual Cost of Revenue for 2021 was $9.29M, a 4.25% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.62M -$417K -20.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $1.94M +$696K +55.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q4 2023 $7.29M $2.23M -$649K -22.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $7.94M $2.04M -$67K -3.19% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $8.01M $1.24M -$598K -32.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $8.61M $1.78M +$8.9K +0.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $8.6M $2.88M +$291K +11.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $8.31M $2.1M -$171K -7.53% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $8.48M $1.84M -$502K -21.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $8.98M $1.77M -$312K -15% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $9.29M $2.59M +$218K +9.19% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $9.07M $2.28M -$78.4K -3.33% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $9.15M $2.34M -$276K -10.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $9.43M $2.09M +$516K +32.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $8.91M $2.37M -$389K -14.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $9.3M $2.35M +$349K +17.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $8.95M $2.62M +$215K +8.94% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $8.74M $1.57M -$703K -30.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $9.44M $2.76M -$655K -19.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-26
Q3 2019 $10.1M $2M +$218K +12.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $9.88M $2.41M -$188K -7.26% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $10.1M $2.27M -$289K -11.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $10.4M $3.41M +$247K +7.79% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $10.1M $1.79M -$955K -34.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $11.1M $2.59M +$325K +14.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $10.7M $2.56M -$5.37K -0.21% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $10.7M $3.17M -$350K -9.94% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-28
Q3 2017 $11.1M $2.74M -$34.9K -1.26% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $11.1M $2.27M -$791K -25.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $11.9M $2.57M -$432K -14.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 $12.4M $3.52M +$405K +13% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 $11.9M $2.78M -$945K -25.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $12.9M $3.06M -$1.45M -32.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $14.3M $3M -$1.44M -32.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 $15.8M $3.11M -$1.89M -37.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 $17.7M $3.72M -$337K -8.31% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $18M $4.51M +$799K +21.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $17.2M $4.43M -$10.4K -0.23% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 $17.2M $5M -$568K -10.2% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 $17.8M $4.06M -$1.81M -30.8% Jul 1, 2014 Sep 30, 2014 10-Q/A 2015-12-28
Q2 2014 $19.6M $3.71M -$2.14M -36.5% Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-12-28
Q1 2014 $21.7M $4.45M -$1.68M -27.4% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-12-28
Q4 2013 $23.4M $5.57M -$2.92M -34.4% Oct 1, 2013 Dec 31, 2013 10-K/A 2015-12-28
Q3 2013 $26.3M $5.86M -$3.07M -34.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $29.4M $5.85M -$4.61M -44.1% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $34M $6.13M -$4.66M -43.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 $38.7M $8.49M -$6.65M -43.9% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-20
Q3 2012 $45.3M $8.93M -$4.54M -33.7% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $49.9M $10.5M -$1.86M -15.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $51.7M $10.8M -$468K -4.16% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 $52.2M $15.1M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-14
Q3 2011 $13.5M +$2.42M +21.9% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $12.3M +$2.73M +28.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $11.2M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
Q3 2010 $11.1M Jul 1, 2010 Sep 30, 2010 10-Q/A 2012-03-06
Q2 2010 $9.59M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.